These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12185880)

  • 1. Interferon-alpha induced transient thyroid dysfunction in hepatitis C.
    Fernández-Díez S; Rodríguez-Agulló JL; Cascudo Rielo MJ; Navarro Angulo N; Díaz-Rubio M
    Rev Esp Enferm Dig; 2002 Mar; 94(3):159-63. PubMed ID: 12185880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
    Gill G; Bajwa H; Strouhal P; Buch HN
    J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
    Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
    Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis C virus infection and thyroid diseases].
    Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
    Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha-induced transient severe hypothyroidism in a patient with Graves' disease.
    Braga-Basaria M; Basaria S
    J Endocrinol Invest; 2003 Mar; 26(3):261-4. PubMed ID: 12809178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study.
    Bini EJ; Mehandru S
    Arch Intern Med; 2004 Nov; 164(21):2371-6. PubMed ID: 15557418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
    Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection.
    Tran HA; Ianna EA; Jones TL; Reeves GE
    QJM; 2012 Jul; 105(7):683-7. PubMed ID: 21690180
    [No Abstract]   [Full Text] [Related]  

  • 11. [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].
    Mekkakia-Benhabib C; Marcellin P; Colas-Linhart N; Castel-Nau C; Buyck D; Erlinger S; Bok B
    Ann Endocrinol (Paris); 1996; 57(5):419-27. PubMed ID: 8991106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C.
    Vasiliadis T; Anagnostis P; Nalmpantidis G; Soufleris K; Patsiaoura K; Grammatikos N; Orfanou-Koumerkeridou E; Kargiotis K; Slavakis A; Deliyiannidis A; Eugenidis N
    Ann Acad Med Singap; 2011 Sep; 40(9):394-400. PubMed ID: 22065032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis.
    Kee KM; Lee CM; Wang JH; Tung HD; Changchien CS; Lu SN; Wang PW
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):319-26. PubMed ID: 16460494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
    Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
    Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
    Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
    Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C.
    Pittau E; Bogliolo A; Tinti A; Mela Q; Ibba G; Salis G; Perpignano G
    Clin Exp Rheumatol; 1997; 15(4):415-9. PubMed ID: 9272304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
    Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
    Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
    Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
    J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.
    Koh LK; Greenspan FS; Yeo PP
    Thyroid; 1997 Dec; 7(6):891-6. PubMed ID: 9459633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.